6533b85efe1ef96bd12c0569

RESEARCH PRODUCT

Role of trastuzumab in infracentimetric HER2-positive breast cancer: The southern Italy experience.

Vincenzo AdamoBarbara AdamoCarmelo IaconoGiuseppina Rosaria Rita RicciardiPietro SpadaroHector Soto-parraLivio BlasiG. LaveniaFrancesco VerderameNicolò BorsellinoGiovanni TuccariAngela PrestifilippoAntonio RussoVittorio GebbiaMichele Caruso

subject

OncologyGynecologyCancer Researchmedicine.medical_specialtybusiness.industryDiseasemedicine.diseaseBreast cancerOncologyTrastuzumabInternal medicineHER2 Positive Breast Cancermedicineskin and connective tissue diseasesbusinessneoplasmsmedicine.drug

description

e11512 Background: HER2 positive (HER2+) disease is relatively uncommon in early infracentimetric breast cancer (BC) accounting for approximately 10% of cases. Trastuzumab (T) based-adjuvant therap...

https://doi.org/10.1200/jco.2014.32.15_suppl.e11512